Back to PollNow

Back to companies

Altimmune, Inc.

ALTUSNASDAQPharmaceuticals & Healthcare

Altimmune, Inc.

Revenue

$41,000

YoY +105.0%

Operating income

-$94.5mn

FY2025

Employees

—

Founded

—

Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API